Aravive To Present New Preliminary Data From Phase 1b Trial Evaluating AVB-500 In Clear Cell Renal Cell Carcinoma At 2021 Society For Immunotherapy Of Cancer Annual Meeting Nov. 13

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!